The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
915
February 4, 1994
View Complete Issue         Table of Contents 2019 
Extended-Release Isosorbide Mononitrate for Angina
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Extended-Release Isosorbide Mononitrate for Angina
February 4, 1994 (Issue: 915)
Isosorbide mononitrate, the major active metabolite of isosorbide dinitrate, was first approved in the USA for oral use in patients with chronic stable angina in 1992 (Medical Letter, 34:61, 1992). Now an extended-release formulation of isosorbide...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Extended-Release Isosorbide Mononitrate for Angina
Article code: 915b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.